News

Hospitalized adults who have COVID-19 are more than 3 times as likely to develop a blood clot than adults who do not have COVID-19, according to new research from Kaiser Permanente Southern California and Kaiser Permanente Northern California. The study published July 20 in CHEST found Black patients as well as patients who had obesity, liver ...

Erin E. Hahn, PHD, MPH, is a health services researcher and implementation scientist. Her primary research interests are quality of care in oncology and the implementation of evidence-informed practices. She is particularly interested in the care of cancer survivors after their initial cancer treatment. Dr. Hahn joined the Department of Research & Evaluation as the ...

A Kaiser Permanente Southern California research study found lower rates of heart failure mortality within the integrated health care system compared to the country as a whole. “In our study, we analyzed the overall rates of death attributable to heart failure throughout the state of California and United States, and then compared that to what we ...

Kaiser Permanente Los Angeles Medical Center is participating in a clinical trial for the Moderna COVID-19 vaccine in children ages 6 months to less than 12 years. The KidCOVE study will evaluate the safety and efficacy of the Moderna COVID-19 vaccine (mRNA-1273), which is the same vaccine that was given Emergency Use Authorization (EUA) in December ...

Kaiser Permanente Los Angeles Medical Center will conduct a multi-centered, randomized, Phase 3 research study to learn if the experimental drug recombinant Factor VIIa (rFVIIA), a protein that our body makes, can be used to decrease bleeding in the brain of patients who suffer sudden bleeding in the brain, also called intracerebral hemorrhage. The study entitled ...

On this day—May 20, 2021, aka Clinical Trials Day—we have more reasons than ever to celebrate the Kaiser Permanente Southern California clinical trials team. We began our COVID-19 clinical trials research with the remdesivir trial in March 2020. We were a top enroller in that study. Since then, our clinical trials program has participated in 9 ...

Kaiser Permanente Southern California’s Department of Research & Evaluation participated in the Health Care Systems Research Network annual conference on May 11 and 12. The conference, “Looking Forward and Embracing Change—Preparedness for the Future During Uncertain Times,”  was held virtually this year after being cancelled in 2020. Over the course of the 2 days, Research & ...

Among insured cancer patients in Southern California, those who were diagnosed and treated at Kaiser Permanente, an integrated health care organization, had better survival rates, especially Black and Latinx patients, according to Kaiser Permanente research published in The American Journal of Managed Care. “Kaiser Permanente is committed to finding and addressing health care inequities,” said the ...